DocSym
β
Searchsearch
Search
(P61.1) Polycythaemia neonatorum
More details coming soon
325 367 in individuals diagnosis polycythaemia neonatorum confirmed
3 002 deaths with diagnosis polycythaemia neonatorum
1% mortality rate associated with the disease polycythaemia neonatorum
Diagnosis polycythaemia neonatorum is diagnosed Men are 12.21% more likely than Women
182 547
Men receive the diagnosis polycythaemia neonatorum
1 628 (0.9 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
142 820
Women receive the diagnosis polycythaemia neonatorum
1 374 (1.0 %)Died from this diagnosis.
Risk Group for the Disease polycythaemia neonatorum - Men and Women aged 0
In Men diagnosis is most often set at age 0-5
Less common in men the disease occurs at Age 5-95+Less common in women the disease occurs at Age 5-29, 35-49, 55-95+
In Women diagnosis is most often set at age 0-5, 30-34, 50-54
Disease Features polycythaemia neonatorum
Absence or low individual and public risk
Polycythaemia neonatorum - what does this mean
Polycythaemia neonatorum is a condition in which newborn babies have an abnormally high number of red blood cells, which can lead to an increased risk of stroke, heart attack, and other complications. it is caused by a variety of factors, including a mother's health during pregnancy, the baby's genetic makeup, and other environmental factors.
What happens during the disease - polycythaemia neonatorum
Polycythaemia neonatorum is a rare condition that occurs when a newborn baby has an abnormally high red blood cell count. it is thought to be caused by a disruption in the normal process of red blood cell production in the bone marrow. this disruption can be caused by many things, including an inherited genetic disorder, a maternal-fetal blood group incompatibility, or an infection in the mother during pregnancy. in some cases, the cause is unknown.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete blood count (CBC) to measure the number of red blood cells
- Blood smear to examine the size and shape of the red blood cells
- Blood chemistry tests to measure the levels of hemoglobin and hematocrit
- Bone marrow aspiration and biopsy to examine the production of red blood cells
- Coagulation tests to measure the clotting ability of the blood
- Ultrasound to assess the size of the spleen
- Genetic testing to identify any mutations in the genes related to the condition
Treatment and Medical Assistance
Main goal of the treatment: Reduce the amount of red blood cells in the body.
- Administering medications to reduce red blood cell production
- Performing a partial exchange transfusion to reduce the amount of red blood cells
- Performing a complete exchange transfusion to replace the infant's blood with donor blood
- Administering a diuretic to reduce the amount of fluid in the body
- Providing oxygen therapy to improve oxygen delivery to the body's tissues
- Performing a bone marrow transplant to replace the infant's faulty bone marrow
11 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Polycythaemia neonatorum - Prevention
Polycythaemia neonatorum can be prevented by ensuring that the newborn has adequate hydration, ensuring that the mother has a healthy pregnancy, and monitoring the newborn's hematocrit levels.
